Bifidumbacterin in intestinal diseases is used inside, and in obstetric-gynecological practice: locally (intravaginally).
1. Treatment and prevention of gastrointestinal diseases:
The contents of the vial to dissolve boiled water at room temperature at the rate of 5 ml (teaspoon) of water per 1 dose of the drug.
Dissolve as follows: pour the required amount of water in a glass (according to the number of doses indicated on the vial); open the bottle by removing the cap and stopper; from the glass to transfer a small amount of water into the bottle; after dissolution (the preparation dissolves no more than 5 minutes with the formation of an opaque homogeneous suspension), the contents of the vial should be transferred to the same beaker and mixed. One teaspoon of the drug dissolved in this way is 1 dose. Dissolved drug is not subject to storage.
The required number of doses (respectively tea spoons) should be taken 20-30 minutes before meals or 1-1.5 hours after eating. Breast children can be given the drug immediately before feeding.
In case of intestinal diseases: for children of the first half-year of life, the drug is prescribed 5 doses per reception 2 times a day, children of the second half and older - 5 doses 3 times a day.
Newborns of the "risk" group should start using the drug in the maternity department from the first day of life to discharge 2.5 doses per reception 2 times a day.
Children with sepsis, pneumonia and other purulent-infectious diseases are prescribed 5 doses 3 times a day in combination with conventional methods of treating the underlying disease. If this group of children has gastrointestinal tract disorders and the threat of ulcerative necrotic enterocolitis, the dose of bifidumbacterin is increased to 20 doses per day.
In acute and chronic inflammatory diseases of the small and large intestine, children older than 3 years and adults are advised to take 5 doses 2-3 times a day. In severe cases, the dose can be doubled.
The duration of treatment with bifidumbacterin is determined by the severity of clinical manifestations, the patient's age and is 2-4 weeks, and in some cases up to 3 months.
With the preventive purpose, the drug is prescribed for 5 doses 1-2 times a day for 1-2 weeks.
2. In obstetrics and gynecology practice:
To treat the nipple area and the areola of the puerperas, the contents of one vial (5 doses) are dissolved in a small amount of cooled boiled water, impregnated with a solution of 2 sterile swabs,which are applied to the nipple and areola for 20-30 minutes before each feeding for 5 days. The tampon impregnated with the drug is left on the surface of the mammary gland before the beginning of the feeding.
With inflammatory diseases of female genitalia and prenatal preparation of pregnant "risk" groups, bifidumbacterin is prescribed for 5-10 doses once a day for 5-8 days under the control of the restoration of vaginal secretion to grade I-II and disappearance of clinical symptoms of the disease.
For intravaginal administration, bifidumbacterin is also dissolved by the above method. The resulting suspension of the drug is impregnated with a sterile swab that is not squeezed intravaginally and left for 2-3 hours.
If necessary, the course of treatment with bifidumbacterin can be repeated.